Commentary: Consensus Guidelines on the Appropriate Use of Brand-Name and Generic Anti-Seizure Medication for the Management of Epilepsy in the Gulf Region Taoufik AlsaadiAbubaker AlmadaniRiaz Ahmed Khan COMMENTARY Open access 24 May 2023 Pages: 1015 - 1031
Clinical Use of On-Demand Therapies for Patients with Parkinson’s Disease and OFF Periods Rajesh PahwaFernando L. PaganMarie Saint-Hilaire REVIEW Open access 23 May 2023 Pages: 1033 - 1049
Comparison Between Burden of Care Partners of Individuals with Alzheimer’s Disease Versus Individuals with Other Chronic Diseases Murat DemirbasJulie H. Hahn-PedersenHenrik L. Jørgensen REVIEW Open access 24 May 2023 Pages: 1051 - 1068
Otogenic Cerebral Sinus Thrombosis in Children: A Narrative Review Michal KotowskiJaroslaw Szydlowski REVIEW Open access 02 June 2023 Pages: 1069 - 1079
Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients Jonathan D. SantoroJennifer GouldJacqueline Palace ORIGINAL RESEARCH Open access 06 April 2023 Pages: 1081 - 1101
Publisher Correction: Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients Jonathan D. SantoroJennifer GouldJacqueline Palace Publisher Correction Open access 10 May 2023 Pages: 1103 - 1103
Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke Mingfeng ZhaiShugang CaoHongbo Liu ORIGINAL RESEARCH Open access 11 May 2023 Pages: 1105 - 1118
Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis Colin Anderson-SmitsMary E. RitcheyJ. Bradley Layton ORIGINAL RESEARCH Open access 12 May 2023 Pages: 1119 - 1132
Predicting the Societal Value of Lecanemab in Early Alzheimer’s Disease in Japan: A Patient-Level Simulation Ataru IgarashiMie Kasai AzumaAmir Abbas Tahami Monfared ORIGINAL RESEARCH Open access 15 May 2023 Pages: 1133 - 1157
Genetic Predisposition to Periodontitis and Risk of Migraine: A Two-Sample Mendelian Randomization Study Zhen-Ni ZhaoZi-Qian ZhangFei-Yan Yu ORIGINAL RESEARCH Open access 15 May 2023 Pages: 1159 - 1169
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study J. Bradley LaytonMary E. RitcheyColin Anderson-Smits ORIGINAL RESEARCH Open access 17 May 2023 Pages: 1171 - 1186
Central Versus Peripheral Drug Exposure Ratio, a Key Differentiator for Siponimod Over Fingolimod? Marc BigaudPamela RamseierGöril Karlsson ORIGINAL RESEARCH Open access 17 May 2023 Pages: 1187 - 1203
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in England Diana WeidlichLaurent ServaisMatthias Bischof ORIGINAL RESEARCH Open access 24 May 2023 Pages: 1205 - 1220
A Multicentre, Randomised, Open-Label, Prospective Study to Estimate the Add-On Effects Of Memantine as Ebixa® Oral Pump (Solution) on Language in Patients with Moderate to Severe Alzheimer’s Disease Already Receiving Donepezil (ROMEO-AD) Hee-** KimYongSoo ShimSeol-Heui Han ORIGINAL RESEARCH Open access 28 May 2023 Pages: 1221 - 1233
Estimating Transition Probabilities Across the Alzheimer’s Disease Continuum Using a Nationally Representative Real-World Database in the United States Amir Abbas Tahami MonfaredShuai FuQuanwu Zhang ORIGINAL RESEARCH Open access 31 May 2023 Pages: 1235 - 1255
A Systematic Review of Clinical Practice Guidelines for Alzheimer’s Disease and Strategies for Future Advancements Amir Abbas Tahami MonfaredN. T. Nhan PhanHarald Hampel ORIGINAL RESEARCH Open access 01 June 2023 Pages: 1257 - 1284
Association Between Admission Hyperglycemia and Outcomes After Endovascular Treatment in Acute Basilar Artery Occlusion Lijiao ZhangFei GaoZhenqian Liu ORIGINAL RESEARCH Open access 02 June 2023 Pages: 1285 - 1297
Ischemic Stroke and Cerebral Microbleeds: A Two-Sample Bidirectional Mendelian Randomization Study Renjie Liu**n ShiXuan Chen ORIGINAL RESEARCH Open access 03 June 2023 Pages: 1299 - 1308
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study Jihad InshasiSamar FaroukRaed Alroughani ORIGINAL RESEARCH Open access 08 June 2023 Pages: 1309 - 1318
Evaluating the Impact of a Training Program in Shared Decision-Making for Neurologists Treating People with Migraine J. Porta-EtessamS. Santos-LasaosaA. L. Guerrero-Peral ORIGINAL RESEARCH Open access 13 June 2023 Pages: 1319 - 1334
Dietary Patterns and Their Associations with Symptom Levels Among People with Multiple Sclerosis: A Real-World Digital Study Lasse SkovgaardPhilipp TrénelAstrid Karnøe Knudsen ORIGINAL RESEARCH Open access 13 June 2023 Pages: 1335 - 1357
Pacemaker Implants and Their Influence on the Daily Life of Patients with Dementia with Lewy Bodies: A Qualitative Case Study Isak HeymanAnnika BrorssonElisabet Londos ORIGINAL RESEARCH Open access 16 June 2023 Pages: 1359 - 1373
Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Single-Center Study Nicolò BruschiMaria MalentacchiMarco Alfonso Capobianco BRIEF REPORT Open access 11 May 2023 Pages: 1375 - 1383
Plasma lncRNA LIPCAR Expression Levels Associated with Neurological Impairment and Stroke Subtypes in Patients with Acute Cerebral Infarction: A Prospective Observational Study with a Control Group Zhong-zhong LiuWen-juan LinSong-di Wu BRIEF REPORT Open access 17 May 2023 Pages: 1385 - 1398
